FMT holds potential for treating various diseases beyond C. difficile infection, but its regulation by the FDA is crucial due to concerns about long-term effects and unintentional disease transfer.
Author: Abhay Panchal
Investigators at Cedars-Sinai have conducted a significant study on inflammatory bowel disease (IBD), identifying key risk factors linked to serious extraintestinal manifestations. Key points:
A prospective video-based study was conducted involving 120 polyps measured and recorded using various measurement tools. Polyps were randomized to visual assessment, snare, forceps, or VSE groups. Eleven endoscopists performed video-based measurements using the assigned tools. The primary outcome was relative accuracy in polyp size measurement compared with caliper measurement immediately post-resection.
The epidemiology of colorectal cancer (CRC) is undergoing significant changes, as highlighted by Folasade May, MD, PhD, MPhil, at the 2023 American College of Gastroenterology meeting. Key shifts include:
This article explores the reluctance of physicians to use algorithm-based technologies in healthcare, despite acknowledging their potential benefits. Key points include:
Introduction Colorectal cancer (CRC) remains a significant public health concern. Recent Medicare policy updates have introduced important changes in CRC screening, particularly affecting medical coding and billing practices. Understanding these updates is essential for medical professionals to ensure compliance and optimal patient care.
Exact Sciences has launched “GoGo Cologuard,” a mobile game to promote colorectal cancer screening. The game features their Cologuard test kit character, “Little C.G.,” in an “endless runner” style gameplay, adding a whimsical touch to encourage screening awareness.
Key points:
The article discusses rollover equity in private equity (PE) acquisitions of physician practices, focusing on how it aligns selling physicians’ interests with the PE partner. In these transactions, a PE-sponsored management services organization (MSO) typically purchases nonclinical aspects of a practice. Consideration for the sale often includes cash and rollover equity in the MSO, usually split around 75-25. Key points: